EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Apolipoprotein C3 Promotes Angiogenesis in an Inflammatory Mouse Model of Peripheral Artery Disease

Jordyn M Thomas iD, Panashe Bamhare, Jocelyne Mulangala, Christina A Bursill iD, Stephen J Nicholls iD, Belinda A Di Bartolo iD, Kristen J Bubb iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202502155r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Jordyn M Thomas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Nursing and Health Sciences, Biomedicine Discovery Institute, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Apolipoprotein C-III, Inflammation, Peripheral Arterial Disease, Neovascularization, Pathologic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MU | Monash Biomedicine Discovery Institute, Monash University (BDI), Monash Biomedicine Discovery Institute, Monash University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apolipoprotein C3 (ApoC3) regulates triglyceride metabolism and is associated with accelerated atherogenesis and adverse cardiovascular outcomes. However, its role in peripheral artery disease (PAD) remains unclear. We investigated whether Apoc3 deficiency impacts key features of PAD. Vascularization was assessed using an inflammatory periarterial cuff model (21 days) and a hind limb ischemia model (14 days) in male and female Apoc3 +/+ and Apoc3 −/− mice. Neovascularization was also assessed in mice following extracellular matrix (ECM) plug implantation. Isolated human umbilical vein endothelial cells (HUVECs) were co‐cultured with ApoC3‐stimulated THP‐1 monocytes, and tubule formation was assessed. Apoc3 ‐deficient mice demonstrated less neovessel formation around the cuffed femoral artery, with endothelial cell (CD31+) staining reduced by approximately 40% compared to Apoc3 +/+ mice. Twenty‐four hours after cuff placement, Apoc3 +/+ vessels exhibited increased expression of angiogenic ( Hif1a and Vegf1 ) and pro‐inflammatory ( Cd68 ) markers, while Apoc3 ‐deficient vessels did not. Confirming a role for inflammation in ApoC3‐induced angiogenesis, tubulogenesis of HUVECs increased only in the presence of ApoC3 and THP‐1 monocytes. Apoc3 deficiency, however, did not affect ischemia‐driven angiogenesis, as there were no differences in revascularization compared to Apoc3 +/+ mice, as assessed by the perfusion index (laser Doppler), fibrosis (Picrosirius red staining), or the mRNA expression of apoptotic ( Bax ), angiogenic ( Hif1a and Vegf1 ), and inflammatory ( Ccl2 , Il6 , and Vcam1 ) markers in the ischemic hind limb. Neovascularization following ECM plug implantation was also unaffected by Apoc3 deficiency. In conclusion, ApoC3 contributes to pathological, inflammation‐driven angiogenesis, highlighting its potential as a therapeutic target for pathological angiogenesis without inhibiting physiological ischemia‐driven angiogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein C-IIIInflammationPeripheral Arterial DiseaseNeovascularization, PathologicNeovascularization, PhysiologicAnimalsMiceHumansMaleFemaleDisease Models, AnimalHuman Umbilical Vein Endothelial CellsMice, KnockoutMice, Inbred C57BLIschemiaMonocytesAngiogenesis

Stichwörter der Autor:innen

apolipoprotein C‐IIIendothelial cellshypoxia‐inducible factor 1 alpha subunit (HIF‐1α)inflammationmacrophagespathological angiogenesisperipheral arterial diseasephysiologic neovascularizationtriglyceridesvascular endothelial growth factor A (VEGFA)

Substanzen

Apolipoprotein C-III

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medicine, Nursing and Health Sciences, Biomedicine Discovery Institute, Clayton, Victoria, Australia.
  • Victorian Heart Institute, Monash University, Clayton, Victoria, Australia.
  • Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • Western Sydney Area Health Service, Westmead Hospital, Sydney, Australia.
  • Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.

ORCID-Profile: Jordyn M Thomas, Christina A Bursill, Stephen J Nicholls, Belinda A Di Bartolo, Kristen J Bubb

Förderung

  • MU | Monash Biomedicine Discovery Institute, Monash University (BDI)
  • Monash Biomedicine Discovery Institute, Monash University

Zitieren

APA

Thomas, J. M., Bamhare, P., Mulangala, J., Bursill, C. A., Nicholls, S. J., Di Bartolo, B. A., & Bubb, K. J. (2025). Apolipoprotein C3 Promotes Angiogenesis in an Inflammatory Mouse Model of Peripheral Artery Disease. The FASEB Journal. https://doi.org/10.1096/fj.202502155r

Vancouver

Thomas JM, Bamhare P, Mulangala J, Bursill CA, Nicholls SJ, Di Bartolo BA, et al. Apolipoprotein C3 Promotes Angiogenesis in an Inflammatory Mouse Model of Peripheral Artery Disease. The FASEB Journal. 2025. doi:10.1096/fj.202502155r

BibTeX
@article{Thomas2025,
  author = {Thomas, Jordyn M and Bamhare, Panashe and Mulangala, Jocelyne and Bursill, Christina A and Nicholls, Stephen J and Di Bartolo, Belinda A and Bubb, Kristen J},
  title = {Apolipoprotein C3 Promotes Angiogenesis in an Inflammatory Mouse Model of Peripheral Artery Disease},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202502155r}
}
Kostenlos starten →